Covid-19 roundup: Pfizer hustling up millions of doses of vaccine — details $748M BioNTech deal; CDC tweaks stance on controversial malaria drugs
Pfizer and BioNTech are ready to outline the details of their ambitious alliance on a Covid-19 mRNA vaccine for the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
